Global Heparin Market is anticipated to grow at a CAGR of 5% by 2026 - Increasing Application of Heparin in Various Surgeries such as Orthopedic and Heart Surgeries

Heparin is an injectable anticoagulant prescription medicine which is used to treat and prevent the symptoms of blood clots caused by various medical conditions or procedures. It is also used to create an anti-clotting surface inside the medical devices such as renal dialysis machines and test tubes.

Growing Utilization of Heparin in Multiple Applications is Driving the Growth of the Heparin Market

Anticoagulants work by decreasing the clotting ability of the blood. It helps to prevent the formation of clots as well as to stop the further expansion of any existing clots. Therefore, it can be used in multiple applications as below:
Prevent or treat certain blood vessel, heart, and lung conditions.
Prevent blood clotting during open-heart surgery, bypass surgery, kidney dialysis and blood transfusions.
Prevention of deep vein thrombosis.
Prevention of a blood clot following percutaneous coronary intervention.

Adoption of Low Molecular Weight Unfractionated Heparin to Prevent Deep Vein Thrombosis or Pulmonary Embolism

Low-molecular-weight heparins have various benefits over UFH that has led to their growing use for several thromboembolic indications such as deep vein thrombosis (DVT) and pulmonary embolism (PE) as well as atrial fibrillation (AF). LMWH provides better bioavailability & longer half-life, simplified dosing, predictable anticoagulant response, lower risk of heparin-induced thrombocytopenia (HIT) and lower risk of osteoporosis over heparin.

Potential Role of Heparin in Covid-19 Patients Boosts the Global Heparin Market

Many patients with COVID-19 symptoms develop a clinically significant coagulopathy. COVID-19 infections can lead to an increased risk of blood clots. These blood clots can lead to patients being admitted to hospital, or, unfortunately in worst cases, their death. Also, patients with COVID-19 are at high risk for developing clinically significant large-vessel thrombosis. Therefore, early use of anticoagulation may reduce the risk of coagulopathy, microthrombus formation, and organ damage.

Rising Market Challenges: Global Heparin Market

The ill-effects associated with the consumption of heparin drugs and the presence of another anticoagulant in the market are the prime factors affecting the growth of the global heparin market.

North America Holds the Highest Market Share but Asia-Pacific is Poised to Witness A Healthy Growth in Heparin Market

Currently, North America holds the largest market share of the heparin market followed by Europe and Asia Pacific. This can be mainly attributed to the growing cases of chronic diseases, presence of advanced and robust healthcare infrastructure, increasing demand for heparin in various surgeries and growing incidences of cardiovascular disorders in this regions.

However, Asia-Pacific is projected to grow rapidly during the forecast period as it is the largest supplier base of crude heparin, rising cases of venous thromboembolism and cardiovascular diseases, rising number of surgical procedures and a rapid growth in the geriatric population in this region.

Competitive Landscape Analysis: Heparin Market

The global heparin market is marked by the presence of established market players such as Baxter International Inc., B. Braun Holding GmbH & Co. KG, Dr. Reddy's Laboratories Ltd., and Fresenius SE & Co KGaA among others.

Companies are Adopting Reliable Growth Strategies to Increase their Market Share in the Global Heparin Market

All major players operating in the global heparin market are adopting both organic and inorganic growth strategies such as collaborations, acquisitions and expansions to garner a higher market share.

For instance,
In February 2022, Techdow USA Inc. announced the launch of its Heparin Sodium Injection, USP in the United States market.
In January 2022, Ohio-based biotechnology company Optimvia Pharmaceuticals announced the development of a synthetic method for creating large quantities of heparin, which is used to make a common blood thinner at a budget price.

Get Detailed Insights on Heparin Market Report with a Sample PDF @ https://meditechinsights.com/global-heparin-market/

Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
info@meditechinsights.com
https://meditechinsights.com/

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services.

This release was published on openPR.